BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9824166)

  • 1. Mdm2 association with p53 targets its ubiquitination.
    Fuchs SY; Adler V; Buschmann T; Wu X; Ronai Z
    Oncogene; 1998 Nov; 17(19):2543-7. PubMed ID: 9824166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.
    Zhou BP; Liao Y; Xia W; Zou Y; Spohn B; Hung MC
    Nat Cell Biol; 2001 Nov; 3(11):973-82. PubMed ID: 11715018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
    Wang W; Takimoto R; Rastinejad F; El-Deiry WS
    Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive mdmx expression during cell growth, differentiation, and DNA damage.
    Jackson MW; Berberich SJ
    DNA Cell Biol; 1999 Sep; 18(9):693-700. PubMed ID: 10492400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2.
    Maki CG
    J Biol Chem; 1999 Jun; 274(23):16531-5. PubMed ID: 10347217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.
    Li L; Liao J; Ruland J; Mak TW; Cohen SN
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1619-24. PubMed ID: 11172000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ability of p53 to activate downstream genes p21(WAF1/cip1) and MDM2, and cell cycle arrest following DNA damage is delayed and attenuated in scid cells deficient in the DNA-dependent protein kinase.
    Kachnic LA; Wu B; Wunsch H; Mekeel KL; DeFrank JS; Tang W; Powell SN
    J Biol Chem; 1999 May; 274(19):13111-7. PubMed ID: 10224064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.
    Ito A; Kawaguchi Y; Lai CH; Kovacs JJ; Higashimoto Y; Appella E; Yao TP
    EMBO J; 2002 Nov; 21(22):6236-45. PubMed ID: 12426395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.
    Shieh SY; Ikeda M; Taya Y; Prives C
    Cell; 1997 Oct; 91(3):325-34. PubMed ID: 9363941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation.
    Feng J; Tamaskovic R; Yang Z; Brazil DP; Merlo A; Hess D; Hemmings BA
    J Biol Chem; 2004 Aug; 279(34):35510-7. PubMed ID: 15169778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover.
    Dumaz N; Milne DM; Jardine LJ; Meek DW
    Biochem J; 2001 Oct; 359(Pt 2):459-64. PubMed ID: 11583595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents.
    Inoue T; Geyer RK; Yu ZK; Maki CG
    FEBS Lett; 2001 Feb; 490(3):196-201. PubMed ID: 11223035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation.
    Zhang Y; Xiong Y
    Science; 2001 Jun; 292(5523):1910-5. PubMed ID: 11397945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor.
    Girnita L; Girnita A; Larsson O
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8247-52. PubMed ID: 12821780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.
    Chandler DS; Singh RK; Caldwell LC; Bitler JL; Lozano G
    Cancer Res; 2006 Oct; 66(19):9502-8. PubMed ID: 17018606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.
    Dumaz N; Meek DW
    EMBO J; 1999 Dec; 18(24):7002-10. PubMed ID: 10601022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt enhances Mdm2-mediated ubiquitination and degradation of p53.
    Ogawara Y; Kishishita S; Obata T; Isazawa Y; Suzuki T; Tanaka K; Masuyama N; Gotoh Y
    J Biol Chem; 2002 Jun; 277(24):21843-50. PubMed ID: 11923280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.
    Hjerrild M; Milne D; Dumaz N; Hay T; Issinger OG; Meek D
    Biochem J; 2001 Apr; 355(Pt 2):347-56. PubMed ID: 11284721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced phosphorylation of p53 serine 18 following DNA damage in DNA-dependent protein kinase catalytic subunit-deficient cells.
    Araki R; Fukumura R; Fujimori A; Taya Y; Shiloh Y; Kurimasa A; Burma S; Li GC; Chen DJ; Sato K; Hoki Y; Tatsumi K; Abe M
    Cancer Res; 1999 Aug; 59(15):3543-6. PubMed ID: 10446957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.